Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)

CAPS Rating: 2 out of 5

A biopharmaceutical company focuses on the discovery, development and commercialization of innovative treatments for infectious diseases

Recs

0
Player Avatar MajorBob04 (98.94) Submitted: 8/13/2012 7:58:59 PM : Underperform Start Price: $6.10 ACHN Score: -78.40

No buyout in sight and negative earnings paint a difficult future.

Featured Broker Partners


Advertisement